Cardio Diagnostics (CDIO) Competitors $3.88 -0.26 (-6.28%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$4.00 +0.13 (+3.22%) As of 08/1/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDIO vs. DYAI, SCYX, ENLV, NRSN, GBIO, NNVC, ALXO, QTTB, FBLG, and RANIShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include Dyadic International (DYAI), SCYNEXIS (SCYX), Enlivex Therapeutics (ENLV), NeuroSense Therapeutics (NRSN), Generation Bio (GBIO), NanoViricides (NNVC), ALX Oncology (ALXO), Q32 Bio (QTTB), FibroBiologics (FBLG), and Rani Therapeutics (RANI). These companies are all part of the "pharmaceutical products" industry. Cardio Diagnostics vs. Its Competitors Dyadic International SCYNEXIS Enlivex Therapeutics NeuroSense Therapeutics Generation Bio NanoViricides ALX Oncology Q32 Bio FibroBiologics Rani Therapeutics Dyadic International (NASDAQ:DYAI) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk. Which has higher valuation and earnings, DYAI or CDIO? Dyadic International has higher revenue and earnings than Cardio Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDyadic International$3.49M8.66-$5.81M-$0.20-5.03Cardio Diagnostics$19.90K339.03-$8.38MN/AN/A Does the media favor DYAI or CDIO? In the previous week, Dyadic International had 3 more articles in the media than Cardio Diagnostics. MarketBeat recorded 3 mentions for Dyadic International and 0 mentions for Cardio Diagnostics. Dyadic International's average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score. Company Overall Sentiment Dyadic International Neutral Cardio Diagnostics Neutral Is DYAI or CDIO more profitable? Dyadic International has a net margin of -163.94% compared to Cardio Diagnostics' net margin of -28,539.39%. Cardio Diagnostics' return on equity of -84.55% beat Dyadic International's return on equity.Company Net Margins Return on Equity Return on Assets Dyadic International-163.94% -233.69% -59.37% Cardio Diagnostics -28,539.39%-84.55%-74.63% Do analysts rate DYAI or CDIO? Dyadic International currently has a consensus target price of $6.00, indicating a potential upside of 497.01%. Cardio Diagnostics has a consensus target price of $60.00, indicating a potential upside of 1,446.39%. Given Cardio Diagnostics' higher probable upside, analysts plainly believe Cardio Diagnostics is more favorable than Dyadic International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dyadic International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Cardio Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals believe in DYAI or CDIO? 28.0% of Dyadic International shares are held by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are held by institutional investors. 29.5% of Dyadic International shares are held by company insiders. Comparatively, 22.3% of Cardio Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more volatility and risk, DYAI or CDIO? Dyadic International has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 2.96, meaning that its share price is 196% more volatile than the S&P 500. SummaryDyadic International beats Cardio Diagnostics on 7 of the 11 factors compared between the two stocks. Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIO vs. The Competition Export to ExcelMetricCardio DiagnosticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.20M$3.00B$5.49B$9.52BDividend YieldN/A2.43%4.73%4.09%P/E RatioN/A17.6228.7523.81Price / Sales339.03179.21372.2066.02Price / CashN/A41.9535.4557.96Price / Book0.558.508.275.55Net Income-$8.38M-$55.06M$3.25B$259.20M7 Day Performance-13.37%-3.99%-3.72%-4.64%1 Month Performance6.89%9.58%4.30%4.41%1 Year Performance-70.61%6.70%25.87%17.95% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOCardio Diagnostics3.1181 of 5 stars$3.88-6.3%$60.00+1,446.4%-71.8%$7.20M$19.90K0.001Gap DownDYAIDyadic International2.0793 of 5 stars$1.00+2.7%$6.00+500.0%-25.6%$29.30M$3.49M-5.007News CoveragePositive NewsGap UpSCYXSCYNEXIS0.4576 of 5 stars$0.71-1.9%N/A-66.6%$28.29M$3.75M-1.2760Upcoming EarningsENLVEnlivex Therapeutics2.4982 of 5 stars$1.19flat$10.00+740.3%+9.8%$28.15MN/A-1.8070News CoverageAnalyst ForecastShort Interest ↑Gap DownNRSNNeuroSense Therapeutics2.0803 of 5 stars$1.93-5.4%$14.00+625.4%+58.8%$27.88MN/A-3.5710News CoverageGap DownGBIOGeneration Bio3.7081 of 5 stars$0.42+3.6%$8.00+1,800.2%-86.7%$27.24M$19.89M-0.39150Upcoming EarningsGap DownHigh Trading VolumeNNVCNanoViricides0.663 of 5 stars$1.69+0.6%N/A-24.8%$27.16MN/A-2.3520Gap DownHigh Trading VolumeALXOALX Oncology3.2601 of 5 stars$0.48-5.3%$3.30+587.5%-81.5%$27.05MN/A-0.1940Gap DownQTTBQ32 Bio1.4406 of 5 stars$2.18-0.5%$12.17+458.1%-94.7%$26.77M$1.16M-0.4439Upcoming EarningsShort Interest ↑FBLGFibroBiologics3.112 of 5 stars$0.67-0.6%$13.00+1,848.4%-87.1%$26.64MN/A-3.1810News CoverageEarnings ReportUpcoming EarningsAnalyst ForecastRANIRani Therapeutics1.757 of 5 stars$0.42+1.1%$7.33+1,646.0%-80.6%$26.27M$1.03M-0.42110Upcoming EarningsShort Interest ↑ Related Companies and Tools Related Companies DYAI Competitors SCYX Competitors ENLV Competitors NRSN Competitors GBIO Competitors NNVC Competitors ALXO Competitors QTTB Competitors FBLG Competitors RANI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDIO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDIO Stock Alerts